Invention Grant
- Patent Title: Tricyclic heterocycles as BET protein inhibitors
- Patent Title (中): 三环杂环作为BET蛋白抑制剂
-
Application No.: US15040475Application Date: 2016-02-10
-
Publication No.: US09533997B2Publication Date: 2017-01-03
- Inventor: Andrew P. Combs , Thomas P. Maduskuie, Jr.
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/06
- IPC: C07D471/06 ; C07D498/06
Abstract:
The present invention relates to tricyclic heterocycles of Formula (I), which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20160159817A1 TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS Public/Granted day:2016-06-09
Information query
